Bridgepoint Group has been focused on protecting inventions in United States(US) with two publications in Q2 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 25% filings and 25% grants. The United States(US), France(FR), Hungary(HU), and European Patent Office(EPO) patent Office are among the top ten patent offices where Bridgepoint Group is filings its patents. Among the top granted patent authorities, Bridgepoint Group has 25% of its grants in United States(US), 25% in European Patent Office(EPO) and 25% in Spain(ES).

AbbVie and Teoxane could be the strongest competitors for Bridgepoint Group

In terms of grant share, Bridgepoint Group stands in third position among its competitors. AbbVie and Teoxane secured the top positions according to recent patent publication data.

For comprehensive analysis of Bridgepoint Group's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

Be better informed